The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss

Nature Immunology

Volumn 13, Issue 5, 2012, Pages 465-473

  Eskan, Mehmet A ^a,b   Jotwani, Ravi ^b   Abe, Toshiharu ^b,g   Chmelar, Jindrich ^c   Lim, Jong Hyung ^c   Liang, Shuang ^b   Ciero, Paul A ^b   Krauss, Jennifer L ^b   Li, Fenge ^b   Rauner, Martina ^c   Hofbauer, Lorenz C ^c   Choi, Eun Young ^c,d,e   Chung, Kyoung Jin ^c   Hashim, Ahmed ^f   Curtis, Michael A ^f   Chavakis, Triantafyllos ^c,e   Hajishengallis, George ^a,b,g  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d University of Ulsan   (South Korea)

^e NATIONAL CANCER INSTITUTE   (United States)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEL 1 PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PROTEIN; UNCLASSIFIED DRUG;

AGING ASSOCIATED PERIODONTITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GERIATRIC DISORDER; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OSTEOLYSIS; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGING; ALVEOLAR BONE LOSS; ANIMALS; CARRIER PROTEINS; CELL ADHESION; ENDOTHELIAL CELLS; FEMALE; INTEGRINS; INTERLEUKIN-17; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; PERIODONTAL ATROPHY; PERIODONTITIS; RECEPTORS, INTERLEUKIN-17;

EID: 84863393385     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2260     Document Type: Article

References (48)

1. Ley, K., Laudanna, C., Cybulsky, M.I. & Nourshargh, S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689 (2007).
2. Luster, A.D., Alon, R. & von Andrian, U.H. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6, 1182-1190 (2005).
3. Chavakis, E., Choi, E.Y. & Chavakis, T. Novel aspects in the regulation of the leukocyte adhesion cascade. Thromb. Haemost. 102, 191-197 (2009).
4. Choi, E.Y. et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322, 1101-1104 (2008).
5. Deban, L. et al. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat. Immunol. 11, 328-334 (2010).
6. Hidai, C., Kawana, M., Kitano, H. & Kokubun, S. Discoidin domain of Del1 protein contributes to its deposition in the extracellular matrix. Cell Tissue Res. 330, 83-95 (2007).
7. Nussbaum, G. & Shapira, L. How has neutrophil research improved our understanding of periodontal pathogenesis? J. Clin. Periodontol. 38, 49-59 (2011).
8. Serhan, C.N., Chiang, N. & Van Dyke, T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349-361 (2008).
9. Pihlstrom, B.L., Michalowicz, B.S. & Johnson, N.W. Periodontal diseases. Lancet 366, 1809-1820 (2005).
10. Genco, R.J. & Van Dyke, T.E. Prevention: reducing the risk of CVD in patients with periodontitis. Nat. Rev. Cardiol 7, 479-480 (2010).
11. Tonetti, M.S. et al. Treatment of periodontitis and endothelial function. N. Engl. J. Med. 356, 911-920 (2007).
12. Lundberg, K., Wegner, N., Yucel-Lindberg, T. & Venables, P.J. Periodontitis in RA-the citrullinated enolase connection. Nat. Rev. Rheumatol. 6, 727-730 (2010).
13. Lalla, E. & Papapanou, P.N. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat. Rev. Endocrinol. 7, 738-748 (2011).
14. Hajishengallis, G. Too old to fight? Aging and its toll on innate immunity. Mol. Oral Microbiol. 25, 25-37 (2010).
15. Huttner, E.A., Machado, D.C., de Oliveira, R.B., Antunes, A.G. & Hebling, E. Effects of human aging on periodontal tissues. Spec. Care Dentist. 29, 149-155 (2009).
16. Cevenini, E. et al. Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr. Pharm. Des. 16, 609-618 (2010).
17. Gomez, C.R., Nomellini, V., Faunce, D.E. & Kovacs, E.J. Innate immunity and aging. Exp. Gerontol. 43, 718-728 (2008).
18. Cascão, R., Rosário, H.S., Souto-Carneiro, M.M. & Fonseca, J.E. Neutrophils in rheumatoid arthritis: more than simple final effectors. Autoimmun. Rev. 9, 531-535 (2010).
19. Liang, S., Hosur, K.B., Domon, H. & Hajishengallis, G. Periodontal inflammation and bone loss in aged mice. J. Periodontal Res. 45, 574-578 (2010).
20. Cua, D.J. & Tato, C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10, 479-489 (2010).
21. Gaffen, S.L. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9, 556-567 (2009).
22. Gaffen, S.L. & Hajishengallis, G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J. Dent. Res. 87, 817-828 (2008).
23. Darveau, R.P. Periodontitis: a polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 8, 481-490 (2010).
24. Li, L. et al. IL-17 produced by neutrophils regulates IFN-γ - mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J. Clin. Invest. 120, 331-342 (2010).
25. Ferretti, S., Bonneau, O., Dubois, G.R., Jones, C.E. & Trifilieff, A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 170, 2106-2112 (2003).
26. Hoshino, A. et al. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner. J. Autoimmun. 31, 79-89 (2008).
27. Brodlie, M. et al. Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease. Eur. Respir. J. 37, 1378-1385 (2011).
28. Lin, A.M. et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J. Immunol. 187, 490-500 (2011).
29. Eustace, A. et al. Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD. Chest 139, 1089-1100 (2011).
30. Lubberts, E. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine 41, 84-91 (2008).
31. Hasturk, H. et al. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J. Immunol. 179, 7021-7029 (2007).
32. Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467-476 (2004).
33. Stark, M.A. et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22, 285-294 (2005).
34. Smith, E. et al. IL-17A inhibits the expansion of IL-17A-producing T cells in mice through "short-loop" inhibition via IL-17 receptor. J. Immunol. 181, 1357-1364 (2008).
35. Lemos, H.P. et al. Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNγ production. Proc. Natl. Acad. Sci. USA 106, 5954-5959 (2009).
36. Graves, D.T., Fine, D., Teng, Y.T., Van Dyke, T.E. & Hajishengallis, G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J. Clin. Periodontol. 35, 89-105 (2008).
37. Weitz-Schmidt, G., Welzenbach, K., Dawson, J. & Kallen, J. Improved lymphocyte function-associated antigen-1 (LFA-1) inhibition by statin derivatives: molecular basis determined by x-ray analysis and monitoring of LFA-1 conformational changes in vitro and ex vivo. J. Biol. Chem. 279, 46764-46771 (2004).
38. Hartl, D. et al. Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. J. Immunol. 181, 8053-8067 (2008).
39. Witowski, J. et al. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GROα chemokine from mesothelial cells. J. Immunol. 165, 5814-5821 (2000).
40. Kempf, T. et al. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat. Med. 17, 581-588 (2011).
41. Ohyama, H. et al. The involvement of IL-23 and the Th17 pathway in periodontitis. J. Dent. Res. 88, 633-638 (2009).
42. Dubin, P.J. & Kolls, J.K. Th17 cytokines and mucosal immunity. Immunol. Rev. 226, 160-171 (2008).
43. Yu, J.J. et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109, 3794-3802 (2007).
44. Chakravarti, A., Raquil, M.A., Tessier, P. & Poubelle, P.E. Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption. Blood 114, 1633-1644 (2009).
45. Lundqvist, C., Baranov, V., Teglund, S., Hammarstrom, S. & Hammarstrom, M.L. Cytokine profile and ultrastructure of intraepithelial γδ T cells in chronically inflamed human gingiva suggest a cytotoxic effector function. J. Immunol. 153, 2302-2312 (1994).
46. Armitage, G.C. Classifying periodontal diseases - a long-standing dilemma. Periodontol. 2000 30, 9-23 (2002).
47. Baker, P.J., Dixon, M. & Roopenian, D.C. Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect. Immun. 68, 5864-5868 (2000).
48. Hajishengallis, G. et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10, 497-506 (2011).